Company Performance: Earnings reports, revenue growth, and profitability all significantly impact investor confidence.

Industry Trends: The overall health and outlook of the biotech/pharmaceutical sector influence stock valuation.

Regulatory Approval: Success or failure in obtaining regulatory approvals for new drugs greatly affects the stock price.

Competition: The emergence of new competitors or competing products can exert downward pressure.

Market Conditions: Broader economic conditions and investor sentiment in the South Korean stock market play a role.

Interest Rates: Changes in interest rates can affect the company's borrowing costs and investment valuations.

Global Events: Geopolitical events and global economic trends can influence investor risk appetite.

Investor Sentiment: Overall investor mood and expectations regarding the company's future prospects.

Management Changes: Changes in key management positions can create uncertainty or instill confidence.

Research & Development: Progress and success in research and development activities directly impact the long-term outlook.

Clinical Trial Results: Positive or negative results from clinical trials are major price catalysts.

Partnerships & Acquisitions: Strategic partnerships and acquisitions can boost investor confidence and stock value.